Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. | EVP, General Counsel | Common Stock | 444K | $2.49M | $5.60 | Mar 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc. | Mar 6, 2024 | 1 | -$323K | 4 | Mar 7, 2024 | EVP, General Counsel |
AUPH | Aurinia Pharmaceuticals Inc. | Feb 20, 2024 | 1 | $0 | 4 | Feb 22, 2024 | EVP, General Counsel |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2023 | 1 | -$172K | 4/A | Feb 22, 2024 | EVP, General Counsel |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2023 | 2 | -$173K | 4 | Mar 6, 2023 | EVP, General Counsel |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2022 | 3 | $0 | 4 | Mar 4, 2022 | EVP, General Counsel |